PDCD1 and neoplasm: To assess the trafficking efficacy of anti-PD-1 drug via normalized blood vessel, immunofluorescence staining was conducted with tumor tissue that was injected with PE-tagged anti-PD-1 antibody at the 6 days instead of anti-PD-1 treatment.